Success Stories: EB-1A Approved for an Associate Research Scientist in the Field of Translational Immunology
Client’s Testimonial:
Thanks very much and appreciate your quick responses all the time. [...] I am happy to recommend you on LinkedIn profile.
We Received EB1-A (Alien of Extraordinary Ability) Approval on March 9th, 2015 for an Associate Research Scientist in the Field of Translational Immunology (Approval Notice)
Position at the Time of Case Filing: Associate Research Scientist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Connecticut
Approval Notice Date: March 9th, 2015
Processing Time: 26 Days (7 days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was an Associate Research Scientist in the Field of Translational Immunology. His specialized research has focused on cancer immunotherapy studies, finding biomarkers for autoimmune disease and developing humanized mouse models of autoimmune diseases, and testing novel biological drugs that induce tolerance. His work had resulted in 25 peer-reviewed scientific articles and 10 presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 240 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also reviewed 12 manuscripts for at least 4 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “In the United States, we desperately [need] research like that being done by [client] in order to combat autoimmune disorders in addition to providing the world ways to produce novel immune therapies aimed at wiping out a wider range of disease. Though we have not personally collaborated on a project, my knowledge of internal medicine and molecular biology, along with [client]’s inventive research work forms the basis for my willingness to offer my wholehearted support in favor of his continued presence in the United States to continue his outstanding research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Translational Immunology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 26 days.